Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors

NCT01450384 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor

Interventions

DRUG: sorafenib tosylate
DRUG: pemetrexed disodium
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]